|
業務類別
|
-- |
|
業務概覽
|
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people. |
| 公司地址
| Zahlerweg 10, Zug, CHE, 6300 |
| 電話號碼
| +41 584558592 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.galderma.com |
| 員工數量
| 7676 |
| Ms. Maria Teresa Hilado |
Independent Director |
05/03/2026 |
| Mr. Marcus Brennecke |
Director |
05/03/2026 |
| Mr. Roberto Marquez |
Independent Director |
05/03/2026 |
| Ms. Sherilyn S. McCoy |
Vice Chairman of the Board |
05/03/2026 |
| Dr. Flemming Ornskov |
Director |
05/03/2026 |
| Mr. Daniel Browne |
Independent Director |
05/03/2026 |
| Ms. Karen L. Ling |
Independent Director |
05/03/2026 |
| Mr. Thomas Ebeling |
Chairman of the Board |
05/03/2026 |
| Mr. Michael Bauer |
Director |
05/03/2026 |
|
|
|
|
